Russell Frank Company’s Harvard Bioscience HBIO Stock Holding History

Russell Frank Company’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$79K	Hold	2,616	–	–	﹤0.01%	2812
2015 Q4	$94K	Hold	2,616	–	–	﹤0.01%	2812
2015 Q3	$98K	Sell	2,616 -710	-21%	-$33K	﹤0.01%	2827
2015 Q2	$190K	Sell	3,326 -416	-11%	-$23.7K	﹤0.01%	2813
2015 Q1	$217K	Hold	3,742	–	–	﹤0.01%	2629
2014 Q4	$208K	Hold	3,742	–	–	﹤0.01%	2612
2014 Q3	$153K	Buy	3,742 +1,635	+78%	+$75.2K	﹤0.01%	2581
2014 Q2	$97K	Buy	+2,107	New	+$88.5K	﹤0.01%	2647
2013 Q4	–	Sell	-2,530	Closed	-$101K	–	2903
2013 Q3	$101K	Buy	2,530 +51	+2%	+$2.01K	﹤0.01%	2949
2013 Q2	$89K	Buy	+2,479	New	+$94.9K	﹤0.01%	2767

Other funds holding HBIO

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Russell Frank Company's HBIO Position: Q1 2016 in Review

Russell Frank Company held its Harvard Bioscience (HBIO) position steady in Q1 2016 at 2,616 shares worth $79K. The position accounts for ﹤0.01% of the portfolio, ranked #2812.

Russell Frank Company first reported a position in HBIO in Q2 2013 and has held it in 10 quarters since. The position peaked at $217K in Q1 2015. 81 funds tracked by Wall St. Rank hold HBIO as of Q1 2016.

Russell Frank Company held 2,616 shares of Harvard Bioscience worth $79K as of Q1 2016.
Russell Frank Company left its Harvard Bioscience share count unchanged in Q1 2016.
Harvard Bioscience made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2812 holding.
Russell Frank Company first reported a position in Harvard Bioscience in Q2 2013 and has held it in 10 quarters since.
Russell Frank Company's Harvard Bioscience position peaked at $217K in Q1 2015.
81 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.